Best practices in sample management & pre-analytical quality control: overcoming challenges in resource-limited laboratory settings Authors: Blessing Kenechi Myke-Mbata, Bruno Basil, Izuchukwu Nnachi Mba, Anthony Osondu Ugwu Published: 2026 ABSTRACT AbstractBackgroundPre-analytical errors remain the leading source of laboratory diagnostic failures worldwide, accounting for approximately 60–75% of errors across the total testing process. These challenges are particularly pronounced in resource-limited settings (RLS), where inadequate infrastructure, unreliable transport systems, workforce shortages, and weak quality management systems compromise specimen integrity and diagnostic accuracy. Despite growing recognition of these barriers, evidence on practical, context-appropriate interventions remains disjointed.ObjectivesThis study synthesizes the current evidence on strategies for strengthening pre-analytical sample management and quality control in RLS and to develop a practical framework for improving diagnostic reliability through adaptive protocols, human-centered quality interventions, and appropriate technologies.MethodA narrative review was conducted using a PRISMA-informed study selection process. Literature published between 2010 and 2025 was identified from PubMed, Scopus, Google Scholar, and grey literature. Eligible studies addressing pre-analytical quality in low- and middle-income countries (LMICs) were critically appraised for methodological quality, operational relevance, and contextual applicability. Evidence from 71 key sources was synthesized using a three-domain conceptual framework comprising adaptive protocols, human-centered quality, and appropriate technology.ResultThe review identified haemolysis, specimen misidentification, clotting, insufficient sample volume, and transport-related degradation as the predominant causes of pre-analytical failure, amplified by systemic weaknesses in resource-limited settings. Evidence demonstrated that context-adapted interventions including standardized phlebotomy practices, dried blood spot sampling, passive cooling systems, motorcycle and drone transport networks, continuous competency-based training, simplified visual standard operating procedures, non-punitive quality cultures, manual quality indicators, and affordable digital laboratory information systems, substantially improve specimen integrity, reduce rejection rates, strengthen traceability, and enhance laboratory efficiency and sustainability.ConclusionStrengthening pre-analytical quality in RLS requires integrated, locally-adaptable interventions rather than replication of high-resource laboratory models. Combining adaptive protocols, empowered healthcare workers, and scalable digital technologies within supportive national policies offers a sustainable pathway to improve diagnostic reliability, patient safety, and health system resilience while advancing equitable access to quality laboratory services.Graphical Abstract Introduction Background Laboratory medicine serves as the foundation of modern healthcare systems and provides objective data that drives the majority of clinical decision-making. Guideline-based analyses demonstrate that laboratory testing is recommended in 73–94% of clinical management pathways across major international guidelines, indicating the pivotal role of laboratory results in medical diagnosis and treatment planning [1, 2]. Consequently, the reliability of these results is paramount for patient safety and effective public health interventions [2–4]. The total testing process (TTP), a concept encompassing every step from the initial test order to the interpretation of the final result, is frequently visualized as a loop that begins and ends with the patient [2, 4]. Although significant technological advancements have improved the precision of the analytical phase (the actual testing of the sample), the pre-analytical phase which includes patient preparation, sample collection, transport, and handling, remains the most vulnerable link in this chain [4–7]. Historical and contemporary data consistently identify the pre-analytical phase as the primary source of laboratory errors. Research indicates that this phase accounts for 60% to 75% of all errors within the TTP [4, 6, 8]. In some settings, this proportion may reach as high as 98%, demonstrating that the greatest threats to diagnostic accuracy occur before the sample even enters the laboratory [7]. Common pre-analytical errors include haemolysis, insufficient sample volume, clotting in anticoagulated tubes, and misidentification or labelling errors [9–12]. The clinical consequences of these errors are severe and include misdiagnosis, inappropriate treatment regimens, delayed care, and the need for repeated venipunctures, which increases patient discomfort and costs [3, 4, 13]. These challenges are significantly amplified in resource-limited settings (RLS), particularly in low- and middle-income countries (LMICs) and sub-Saharan Africa (SSA) [8, 14, 15]. In these environments, laboratories operate under profound systemic constraints that act as force multipliers for error. Infrastructure deficits are a primary barrier. Unreliable electricity grids often disrupt the “cold chain” required to preserve sample stability during storage and transport, leading to degradation of sensitive analytes [14, 16]. Furthermore, a chronic shortage of skilled laboratory professionals and high staff turnover rates mean that phlebotomy and sample handling are frequently performed by non-laboratory personnel with limited training, directly contributing to high rates of haemolysis and sample rejection [14, 17, 18]. Logistics present another formidable hurdle, as weak transport networks and poor road conditions delay sample arrival at testing centers, further compromising specimen integrity [15, 19]. The impact of these failures extends beyond individual patient harm to the health system as a whole. High rejection rates, which can exceed 10% in some African cohorts for specific tests like HIV serology or coagulation profiles, represent a substantial financial waste in systems where resources are already scarce [12, 13, 20–22]. Crucially, this creates an operational paradox for priority specimens such as cerebrospinal fluid and blood cultures. Because these invasive, time-critical samples cannot be readily recollected, they are rarely rejected despite compromised pre-analytical quality. Consequently, laboratories must devote substantial time and resources to processing specimens that may ultimately yield unreliable or clinically misleading results. Moreover, persistent unreliability in laboratory services erodes clinician and community trust, leading to the underutilization of diagnostic tools and a reliance on empirical treatment, which can fuel antimicrobial resistance [15, 23–25]. Thus, pre-analytical error in RLS is not merely a technical issue but a symptom of broader health system fragility that requires targeted, context-aware interventions. Rationale for a narrative review Addressing pre-analytical quality in RLS requires a synthesis that reflects the complexity and contextual variability of laboratory practice. Although systematic reviews and meta-analyses are well suited to narrowly defined interventions, they are less effective for complex topics where best practices depend on local infrastructure, workforce capacity, and health system organization [26, 27]. The literature on laboratory quality in low- and middle-income countries is heterogeneous, encompassing peer-reviewed studies alongside grey literature such as technical reports, implementation guides, and field case studies. A narrative review allows these diverse sources to be integrated, supporting the synthesis of theoretical frameworks, emerging innovations, and context-specific lessons that may be excluded by rigid methodological approaches [26, 27]. This format is therefore well suited to bridging academic rigor and operational relevance in pre-analytical quality improvement. Aim and scope of the review This review focuses on strategies to strengthen sample management and pre-analytical quality control in RLS settings. It covers three key thematic areas including resilient approaches to sample collection and transport, human-centered strategies for minimizing pre-analytical errors, and the use of locally-adaptable digital tools to enhance oversight and data integrity. In this study, we aim to synthesize the available evidence across these domains and provide a coherent, practical framework to improve diagnostic reliability and pre-analytical performance in underserved health systems. The specific objectives include: To characterize the major pre-analytical challenges affecting specimen quality and diagnostic reliability. To characterize the major pre-analytical challenges affecting specimen quality and diagnostic reliability. To synthesize evidence on adaptable sample collection and transport practices that preserve specimen integrity in resource-limited settings. To synthesize evidence on adaptable sample collection and transport practices that preserve specimen integrity in resource-limited settings. To examine human-centered strategies, including training approaches and simplified SOPs, for reducing pre-analytical errors. To examine human-centered strategies, including training approaches and simplified SOPs, for reducing pre-analytical errors. To evaluate the contribution of locally-adaptable digital technologies to pre-analytical quality control and data integrity. To evaluate the contribution of locally-adaptable digital technologies to pre-analytical quality control and data integrity. To integrate these evidence-based elements into a practical framework for improving diagnostic reliability in underserved laboratory systems. To integrate these evidence-based elements into a practical framework for improving diagnostic reliability in underserved laboratory systems. Methods Methodological design This report utilizes a narrative review methodology to synthesize a diverse body of evidence concerning pre-analytical sample management and quality control. The goal is to construct a holistic picture of the challenges and solutions available to laboratories operating in RLS. This study adopts a multi-dimensional research approach that triangulates data from peer-reviewed academic literature, technical reports, and implementation guidelines from global health organizations. This approach is essential to capture the complexity of the laboratory environment in LMICs. Its design allows for a balanced assessment that contrasts the theoretical potential of interventions with their practical scalability and sustainability. Conceptual framework This review is organized around a three-domain conceptual framework comprising adaptive protocols, human-centered quality, and appropriate technology (Fig. 1). The framework is informed by the socio-technical systems paradigm, which emphasizes that effective organizational performance depends on the interaction between processes, people, and technology [14, 15, 28]. Applied to pre-analytical laboratory practice, these domains provide a practical structure for examining how laboratories in resource-limited settings can strengthen specimen management and reduce diagnostic errors. Adaptive Protocols address the process dimension by examining how laboratory procedures can be modified to remain reliable despite infrastructural constraints, such as unstable electricity, limited cold-chain capacity, or transportation delays. Adaptive Protocols address the process dimension by examining how laboratory procedures can be modified to remain reliable despite infrastructural constraints, such as unstable electricity, limited cold-chain capacity, or transportation delays. Human-Centered Quality focuses on the people dimension, exploring the workforce practices, training strategies, and organizational culture needed to maintain consistent quality under demanding operational conditions. Human-Centered Quality focuses on the people dimension, exploring the workforce practices, training strategies, and organizational culture needed to maintain consistent quality under demanding operational conditions. Appropriate Technology represents the tools dimension, evaluating affordable, scalable, and maintainable technological solutions that support specimen tracking, monitoring, and quality assurance in low-resource environments. Appropriate Technology represents the tools dimension, evaluating affordable, scalable, and maintainable technological solutions that support specimen tracking, monitoring, and quality assurance in low-resource environments. The Three Pillars of Intervention Conceptual Framework. The framework illustrates how strengthening pre-analytical quality in resource-limited settings requires the coordinated interaction of adaptive protocols (processes), human-centered quality (people), and appropriate technology (tools). Built on the operational realities of resource-constrained environments, these three complementary pillars collectively support improved pre-analytical quality and specimen integrity, providing a practical framework for reducing diagnostic errors and strengthening resilient laboratory systems These three domains correspond directly to the objectives of this review and provide an integrated framework for synthesizing the evidence. The framework is consistent with health systems strengthening approaches, which recognize that sustainable improvements in laboratory performance require coordinated advances in procedures, workforce capacity, and supporting technologies. Organizing the evidence in this way facilitates a systematic examination of how these complementary domains contribute to resilient pre-analytical laboratory systems in resource-limited settings. Information sources and search strategy The review draws upon a comprehensive dataset of materials covering the period from 2010 to 2025. To ensure a robust collection of relevant evidence, a detailed search was executed across primary bibliographic databases including PubMed, Scopus, and Google Scholar. To ensure high sensitivity and coverage of both scientific validation and field implementation, the search strategy employed a Boolean logic combining keywords and free-text terms organized into three distinct clusters: Cluster 1 (Core Subject & Phase): “Sample management” OR “specimen handling” OR “pre-analytical errors” OR “pre-analytic” OR “sample integrity” OR “phlebotomy”. Cluster 1 (Core Subject & Phase): “Sample management” OR “specimen handling” OR “pre-analytical errors” OR “pre-analytic” OR “sample integrity” OR “phlebotomy”. Cluster 2 (Interventions & Technologies): “Dried Blood Spots” OR “DBS” OR “laboratory logistics” OR “digital tracking” OR “Basic Laboratory Information System” OR “BLIS” OR “passive cooling” OR “appropriate technology”. Cluster 2 (Interventions & Technologies): “Dried Blood Spots” OR “DBS” OR “laboratory logistics” OR “digital tracking” OR “Basic Laboratory Information System” OR “BLIS” OR “passive cooling” OR “appropriate technology”. Cluster 3 (Context/Region): “Resource-limited settings” OR “low-and-middle-income countries” OR “LMICs” OR “Sub-Saharan Africa” OR “remote laboratories” OR “low-resource”. Cluster 3 (Context/Region): “Resource-limited settings” OR “low-and-middle-income countries” OR “LMICs” OR “Sub-Saharan Africa” OR “remote laboratories” OR “low-resource”. The three clusters were combined using the Boolean operator AND to retrieve studies addressing all three conceptual domains. The master search strategy was: (“Sample management” OR “specimen handling” OR “pre-analytical errors” OR “pre-analytic” OR “sample integrity” OR “phlebotomy”) AND (“Dried Blood Spots” OR “DBS” OR “laboratory logistics” OR “digital tracking” OR “Basic Laboratory Information System” OR “BLIS” OR “passive cooling” OR “appropriate technology”) AND (“Resource-limited settings” OR “low-and-middle-income countries” OR “LMICs” OR “Sub-Saharan Africa” OR “remote laboratories” OR “low-resource”). Grey literature was also searched to identify technical reports, guidelines, and implementation resources from organizations including the World Health Organization (WHO), the U.S. Centers for Disease Control and Prevention (CDC), particularly the Laboratory Quality Management System (LQMS) training toolkit, and the Clinical and Laboratory Standards Institute (CLSI). In addition, the reference lists of included articles were manually screened to identify further relevant studies. Eligibility criteria Eligibility was determined based on specific inclusion and exclusion criteria to ensure the relevance and transferability of the reviewed material. The inclusion criteria prioritized studies published between 2010 and 2025 that explicitly addressed the pre-analytical phase of sample management in clinical or biomedical laboratories situated in resource-limited environments. All study designs including original research, reviews, case studies, and technical reports were considered to ensure a rich evidence base. Exclusion criteria were applied to studies focused exclusively on the analytical or post-analytical phases, or research conducted in high-resource settings that did not present principles or technologies demonstrably transferable to RLS. Data extraction, quality appraisal, and synthesis Study selection followed a structured PRISMA-informed process (Fig. 2) to ensure transparent identification, screening, and inclusion of evidence sources. A total of 142 records were identified through systematic electronic database searches and grey literature mining. Following deduplication, 118 records underwent title and abstract screening, after which 89 full-text articles were assessed. To ensure methodological soundness, each paper was appraised using a pragmatic quality assessment protocol focusing on technical depth, data reliability, operational feasibility, and geographic relevance to resource-limited laboratories. PRISMA-informed Flow Diagram. Flowchart illustrating the identification, screening, eligibility assessment, and final inclusion of studies used for thematic synthesis in this narrative review Of the eligible papers, 71 sources were selected for final thematic synthesis based on both eligibility and criticality for analytical depth and contextual relevance. Priority was given to studies offering distinct empirical, programmatic, or operational insights into adaptive protocols, human-centered quality workflows, and digital tracking tools. A small number of additional sources (6) were included to support foundational concepts and framework development. The remaining 12 sources were excluded from the core analysis because they introduced thematic saturation and conceptual redundancy, offering no unique data beyond the higher-quality, context-specific citations already selected. Data extraction and synthesis focused on capturing key metrics across the core intervention areas. Extracted data points were subsequently organized using a matrix framework to analyze the operational interactions between protocols, workforce behaviours, and technology implementations in resource-constrained laboratory environments. Result The findings are synthesized to characterize the principal pre-analytical challenges affecting specimen quality and diagnostic reliability, followed by an evaluation of adaptive protocols, human-centered quality interventions, and appropriate technologies, before integrating these evidence-based strategies into practical implementation approaches for resource-limited settings. The burden and dynamics of pre-analytical errors in resource-limited settings The pre-analytical phase represents the most perilous segment of the total testing process (TTP) in laboratory medicine accounting for about 60% to 75% of all laboratory errors [4, 6, 7, 9]. However, in RLS, this baseline vulnerability is profoundly exacerbated by systemic fragility, creating a distinct and more severe error profile [8, 14, 15]. Patterns and prevalence of errors In the African context, the prevalence of pre-analytical errors is significantly higher than in well-resourced environments. A systematic review and meta-analysis of clinical laboratory errors in Africa reported a pooled prevalence of pre-analytical errors of 17.5% (95% CI 11.55–23.45), a figure markedly higher than global averages, where pre-analytical error rates are often below 5%. [8]. While analytical errors have decreased substantially due to the widespread adoption of automated analysers, pre-analytical processes remain largely manual and operator-dependent, making them prone to failure [4, 7, 9]. A 2022 two-year retrospective tertiary hospital-based study across 55,345 clinical chemistry test requests found an overall pre-analytical error rate of 12.1%, with haemolysis and collection volume errors consistently ranking as the leading deficiencies [11]. The typology of these errors is heterogeneous but shows consistent patterns across the continent. These errors are primarily driven by inadequate phlebotomy technique, manual identification and labelling processes, insufficient staff training, delayed transport, weak cold-chain infrastructure, and poor adherence to standardized collection protocols, all of which are magnified in resource-limited settings. Haemolysis: This is frequently the leading cause of sample rejection. Data from multiple studies indicate that haemolysis accounts for 16% to 29% of all unsuitable samples [12]. In emergency departments, where collection is often hurried and performed by non-laboratory staff, haemolysis rates have been documented as high as 17.2% [29]. A study in Cameroon found that 27.8% of errors in HIV viral load testing were due to quality issues like haemolysis [30]. Haemolysis: This is frequently the leading cause of sample rejection. Data from multiple studies indicate that haemolysis accounts for 16% to 29% of all unsuitable samples [12]. In emergency departments, where collection is often hurried and performed by non-laboratory staff, haemolysis rates have been documented as high as 17.2% [29]. A study in Cameroon found that 27.8% of errors in HIV viral load testing were due to quality issues like haemolysis [30]. Identification and Labelling: In contrast to high-resource settings where barcode scanning is ubiquitous, RLS often rely on handwritten labels, leading to high rates of clerical error. In a Nigerian public clinical laboratory, incomplete or incorrect specimen labelling accounted for a staggering 59.8% of all rejected samples [21]. Similarly, in Cameroon, specimen identification errors constituted 63.14% of non-conformities for viral load testing [30]. Identification and Labelling: In contrast to high-resource settings where barcode scanning is ubiquitous, RLS often rely on handwritten labels, leading to high rates of clerical error. In a Nigerian public clinical laboratory, incomplete or incorrect specimen labelling accounted for a staggering 59.8% of all rejected samples [21]. Similarly, in Cameroon, specimen identification errors constituted 63.14% of non-conformities for viral load testing [30]. Clotting and Volume: Clotted samples, resulting from insufficient mixing of blood with anticoagulants, are another major source of rejection [12]. In a retrospective analysis in Rwanda, clotting was responsible for 46.4% of sample rejections [31]. Clotting and Volume: Clotted samples, resulting from insufficient mixing of blood with anticoagulants, are another major source of rejection [12]. In a retrospective analysis in Rwanda, clotting was responsible for 46.4% of sample rejections [31]. The major categories of pre-analytical errors, their underlying causes, and clinical consequences in resource-limited settings are summarized in Table 1. Table 1Typology of pre-analytical errors in resource-limited settings [4, 9–12, 21, 29–35]Error typeFrequency/prevalencePrimary causes in RLS contextClinical/systemic impactHaemolysis ~ 16–29% of unsuitable samples; leading cause of rejectionUse of syringes; poor phlebotomy technique; inadequate trainingFalse elevation of potassium, LDH; assay interference; misdiagnosisMisidentification/Labelling Errors ~ 8–60% depending on system (higher in manual workflows)Absence of barcode systems; high workload; failure of patient identification protocolsRisk of transfusion errors; incorrect treatment; patient harmClotted Samples ~ 5–46% of rejected samples (context-dependent)Inadequate mixing; expired tubes; difficult venipunctureSample rejection; unreliable haematology indicesInsufficient Volume ~ 10–20% of poor-quality samplesPoor venipuncture; early tube removal; untrained personnelIncorrect anticoagulant ratio; inability to perform testsSample DegradationVariable; major contributor to rejectionDelayed transport; lack of cold chain; prolonged turnaround timeLoss of analyte integrity (e.g., glucose); delayed diagnosisInappropriate Test Requests ~ 11–70% depending on settingPoor guideline adherence; limited clinician trainingResource wastage; unnecessary follow-up testing Typology of pre-analytical errors in resource-limited settings [4, 9–12, 21, 29–35] The amplification effect of systemic constraints The high error rates in RLS are not merely the result of individual negligence but are driven by a “systemic amplification effect” where infrastructure, material and workforce constraints multiply the risk of failure (Fig. 3). Logistical Delays: The final stages of sample transport present a critical challenge. In Kenya, a study at the Kenyatta National Hospital revealed that 34.5% of rejected CD4/CD8 samples were discarded solely because they arrived more than 48 h after collection, rendering the cells unviable for analysis [19, 35]. This delay is particularly devastating for Antimicrobial Resistance (AMR) surveillance; unlike viral nucleic acids which possess relative stability, fastidious bacteria such as Streptococcus pneumoniae suffer rapid viability loss without immediate inoculation into transport media (e.g., Amies), effectively rendering the sample useless for sensitivity profiling [23, 36]. Logistical Delays: The final stages of sample transport present a critical challenge. In Kenya, a study at the Kenyatta National Hospital revealed that 34.5% of rejected CD4/CD8 samples were discarded solely because they arrived more than 48 h after collection, rendering the cells unviable for analysis [19, 35]. This delay is particularly devastating for Antimicrobial Resistance (AMR) surveillance; unlike viral nucleic acids which possess relative stability, fastidious bacteria such as Streptococcus pneumoniae suffer rapid viability loss without immediate inoculation into transport media (e.g., Amies), effectively rendering the sample useless for sensitivity profiling [23, 36]. Cold Chain Failures: The absence of reliable electricity grids means that maintaining temperature control during these delays is often impossible. Samples are frequently exposed to ambient temperatures that degrade labile analytes (e.g., glucose, ACTH) long before they reach the testing facility [14, 16, 32, 37]. Cold Chain Failures: The absence of reliable electricity grids means that maintaining temperature control during these delays is often impossible. Samples are frequently exposed to ambient temperatures that degrade labile analytes (e.g., glucose, ACTH) long before they reach the testing facility [14, 16, 32, 37]. Workforce Capacity: Chronic staff shortages necessitate task-shifting, where phlebotomy is performed by overworked nurses or junior clinical staff rather than trained phlebotomists. This lack of specialized training is a direct driver of the high haemolysis and clotting rates observed [17, 18, 33]. Workforce Capacity: Chronic staff shortages necessitate task-shifting, where phlebotomy is performed by overworked nurses or junior clinical staff rather than trained phlebotomists. This lack of specialized training is a direct driver of the high haemolysis and clotting rates observed [17, 18, 33]. Consumable and Supply Scarcity: Limited and inconsistent availability of essential sampling consumables including butterfly needles, appropriately sized collection tubes, non-expired blood collection devices, and suitable antiseptics, frequently forces healthcare workers to improvise or reuse suboptimal materials. These supply constraints increase the risk of haemolysis, inadequate sample volume, contamination, clotting, and specimen rejection, thereby undermining pre-analytical quality and diagnostic reliability in resource-limited settings [14, 16, 17, 33]. Consumable and Supply Scarcity: Limited and inconsistent availability of essential sampling consumables including butterfly needles, appropriately sized collection tubes, non-expired blood collection devices, and suitable antiseptics, frequently forces healthcare workers to improvise or reuse suboptimal materials. These supply constraints increase the risk of haemolysis, inadequate sample volume, contamination, clotting, and specimen rejection, thereby undermining pre-analytical quality and diagnostic reliability in resource-limited settings [14, 16, 17, 33]. Ishikawa diagram illustrating the systemic drivers of pre-analytical errors in resource-limited settings. This root-cause analysis highlights how environmental and infrastructural constraints amplify human and process-related errors Clinical and economic implications The consequences of these pre-analytical failures are both clinical and economic, creating a vicious cycle of waste and inefficiency. Economic Waste: The direct cost of rejected samples is measurable and significant. A cost analysis study estimated the direct cost per rejected sample at approximately €2.10 (calculated in a Turkish setting), a figure that scales into thousands of euros annually even for mid-sized laboratories [13]. In RLS, where reagents are often imported and scarce, this represents a catastrophic waste of resources. “Internal failure costs,” such as the labour required for re-testing and instrument downtime caused by clotted samples, further drain limited budgets [13, 20]. Economic Waste: The direct cost of rejected samples is measurable and significant. A cost analysis study estimated the direct cost per rejected sample at approximately €2.10 (calculated in a Turkish setting), a figure that scales into thousands of euros annually even for mid-sized laboratories [13]. In RLS, where reagents are often imported and scarce, this represents a catastrophic waste of resources. “Internal failure costs,” such as the labour required for re-testing and instrument downtime caused by clotted samples, further drain limited budgets [13, 20]. Clinical Harm and Erosion of Trust: The external failure costs are even higher. Misidentification errors carry the risk of fatal transfusion reactions or inappropriate medication administration. High rejection rates lead to delayed diagnosis which is critical in conditions like paediatric HIV, where early initiation of therapy is lifesaving. Ultimately, persistent unreliability erodes the trust of clinicians and patients in laboratory services, leading to the underutilization of diagnostic tools and a reliance on empirical treatment [3, 15, 22, 24]. Clinical Harm and Erosion of Trust: The external failure costs are even higher. Misidentification errors carry the risk of fatal transfusion reactions or inappropriate medication administration. High rejection rates lead to delayed diagnosis which is critical in conditions like paediatric HIV, where early initiation of therapy is lifesaving. Ultimately, persistent unreliability erodes the trust of clinicians and patients in laboratory services, leading to the underutilization of diagnostic tools and a reliance on empirical treatment [3, 15, 22, 24]. Optimizing sample collection and stabilization protocols Given that the point of collection is the epicentre of error, interventions must target this critical control point. The vulnerability of the “vein-to-lab” journey in RLS necessitates protocols that are not just standardized but adaptive to the environment. Phlebotomy as a critical control point Phlebotomy is a complex invasive procedure where technique directly determines sample integrity. The high prevalence of haemolysis which is often caused by using small-gauge needles, vigorous mixing, or prolonged tourniquet application, highlights the need for rigorous technical standardization [33, 34, 38, 39]. Device Selection: The use of appropriate collection devices is paramount. While evacuated tube systems (e.g., Vacutainer) are standard, their cost can be prohibitive in smaller facilities. However, using syringes and needles for transfer to tubes is a known risk factor for haemolysis due to the shear stress placed on red blood cells during the transfer and also increases the risk of needlestick injuries and occupational blood exposure for healthcare workers [34, 40]. Device Selection: The use of appropriate collection devices is paramount. While evacuated tube systems (e.g., Vacutainer) are standard, their cost can be prohibitive in smaller facilities. However, using syringes and needles for transfer to tubes is a known risk factor for haemolysis due to the shear stress placed on red blood cells during the transfer and also increases the risk of needlestick injuries and occupational blood exposure for healthcare workers [34, 40]. Patient Identification: To mitigate the high rate of labelling errors (exceeding 60% in some Sri Lankan cohorts) [41], protocols must enforce “active identification” such as asking the patient to state their name and date of birth, and labelling the tube in the presence of the patient before leaving the bedside [12, 40, 42]. Patient Identification: To mitigate the high rate of labelling errors (exceeding 60% in some Sri Lankan cohorts) [41], protocols must enforce “active identification” such as asking the patient to state their name and date of birth, and labelling the tube in the presence of the patient before leaving the bedside [12, 40, 42]. Unique challenges in point-of-care (POC) capillary sampling Although POCT decentralizes diagnostics, it introduces unique pre-analytical risks distinct from venipuncture, specifically regarding capillary sampling. Inconsistent technique, such as milking the finger to force blood flow, causes haemolysis and introduces interstitial fluid that dilutes the sample, leading to significantly erroneous glucose or haemoglobin results [43]. To counter this, protocols must strictly enforce the warming of the puncture site to increase perfusion and the mandatory wiping away of the first drop of blood to ensure sample representativeness [44, 45]. Adaptive protocols: dried blood spots (DBS) To bypass the constraints of the cold chain and logistical delays, Dried Blood Spots (DBS) have emerged as a cornerstone adaptive technology [46]. DBS samples are collected on filter paper and air-dried, rendering them stable at ambient temperatures for weeks. This eliminates the need for refrigeration during transport, effectively solving the cold chain crisis for stable analytes. They can be collected via a simple finger-prick, enabling collection by lower-cadre health workers or even lay peers, thus expanding access to remote populations. DBS is the standard of care for Early Infant Diagnosis (EID) of HIV and viral load monitoring in many African nations. However, it is not without limitations. The haematocrit effect, where variations in blood viscosity affect sample spread and volume, can compromise volumetric precision because high-haematocrit blood spreads less on filter paper, concentrating more analyte in a fixed punch, while low-haematocrit samples spread more widely and dilute the analyte per punch [47]. Furthermore, while excellent for nucleic acids (DNA/RNA), DBS has limitations for sensitive clinical chemistry analytes like lipids, which may degrade over time [48]. A comparative overview of DBS and conventional venipuncture across key operational parameters in resource-limited settings is presented in Table 2. Table 2Comparative analysis of dried blood spots (DBS) vs traditional venipuncture [20, 29, 32, 43–48]ParameterDried blood spots (DBS)Traditional venipunctureCollection personnelCan be performed by trained non-specialist health workersRequires trained phlebotomistSampling materialsMinimal (lancet, filter paper, desiccant, alcohol swab, compress)Multiple consumables (vacutainers, needles, tubes, alcohol swabs, compresses)Cold chain dependencyLow; stable at ambient temperaturesHigh; requires refrigeration/freezingTransport & storageSimple, low-cost; can use standard mail systems; requires triple packagingRequires temperature-controlled logistics with triple packagingSample volumeLimited (fixed volume per spot)Flexible (multi-mL; supports repeat testing)Biohazard riskReduced due to dryingHigher; liquid blood handling risksKey limitationsHaematocrit effect; limited analyte range; technique-sensitiveHaemolysis, clotting, infrastructure dependenceCost profileLower transport and collection cost; higher analytical complexityHigher logistics cost; standardized lab workflows Comparative analysis of dried blood spots (DBS) vs traditional venipuncture [20, 29, 32, 43–48] Impact of training on error reduction Evidence demonstrates that when phlebotomy is shifted from untrained staff to a dedicated, trained phlebotomy team, or when nurses undergo targeted competency training, rejection rates drop significantly. A study in an emergency department showed that implementing a new blood collection method with standardized equipment reduced haemolysis rates from 7.3% to 1.9% [38]. This confirms that technical errors like haemolysis are largely preventable through training and protocol adherence [18, 38, 39]. Addressing logistical barriers: transport and storage solutions Bridging the gap between a peripheral clinic and a central laboratory requires innovations that do not rely on non-existent infrastructure. Passive cooling innovations In the absence of continuous electricity, passive cooling technologies are essential for preserving sample integrity. However, cooling must be paired with rigorous biosafety. Adherence to UN 3373 Category B standards is non-negotiable but can be achieved frugally using a Triple Packaging System adapted for limited resources [49, 50]. This involves a leak-proof primary vessel, a secondary water-tight container with absorbent material, and a rigid outer shell. Field implementations have successfully utilized locally sourced, sealable plastic containers to meet these crush-proof standards, ensuring that courier safety parallels sample integrity. Evaporative Cooling: Low-tech solutions like the Zeer pot (a pot-in-pot refrigerator using wet sand) or the Cambodian Cooler Box utilize evaporative cooling to maintain temperatures significantly lower than ambient heat. While they may not reach 2–8 °C in all climates, they effectively prevent the extreme heat spikes that destroy samples [51]. Evaporative Cooling: Low-tech solutions like the Zeer pot (a pot-in-pot refrigerator using wet sand) or the Cambodian Cooler Box utilize evaporative cooling to maintain temperatures significantly lower than ambient heat. While they may not reach 2–8 °C in all climates, they effectively prevent the extreme heat spikes that destroy samples [51]. Phase-Change Materials (PCMs): Modern transport coolers utilizing phase-change materials (specialized gel packs) can maintain strict temperature ranges for extended periods (e.g., 24–72 h) without external power. These are critical for transporting whole blood or vaccines [52, 53]. Phase-Change Materials (PCMs): Modern transport coolers utilizing phase-change materials (specialized gel packs) can maintain strict temperature ranges for extended periods (e.g., 24–72 h) without external power. These are critical for transporting whole blood or vaccines [52, 53]. Innovative transport models Two models have shown particular promise in RLS for moving the sample physically: Motorcycle Courier Networks: Organizations like Riders for Health manage fleets of motorcycles to create scheduled specimen pick-up loops. This reliable, ground-based logistics network has been shown to drastically reduce turnaround times for HIV and TB testing in Nigeria and other nations [19]. It is a human-centric solution that creates local employment and is robust against poor road conditions. Motorcycle Courier Networks: Organizations like Riders for Health manage fleets of motorcycles to create scheduled specimen pick-up loops. This reliable, ground-based logistics network has been shown to drastically reduce turnaround times for HIV and TB testing in Nigeria and other nations [19]. It is a human-centric solution that creates local employment and is robust against poor road conditions. Drone Delivery (UAVs): Unmanned Aerial Vehicles (drones) represent a rapid advancement technology. Services like Zipline in Rwanda and Ghana have demonstrated the ability to transport blood products and samples over impassable terrain in minutes rather than hours [54]. Although the upfront capital is higher, the speed and independence from ground infrastructure make drones a powerful tool for emergency diagnostics and hard-to-reach areas (Fig. 4). Drone Delivery (UAVs): Unmanned Aerial Vehicles (drones) represent a rapid advancement technology. Services like Zipline in Rwanda and Ghana have demonstrated the ability to transport blood products and samples over impassable terrain in minutes rather than hours [54]. Although the upfront capital is higher, the speed and independence from ground infrastructure make drones a powerful tool for emergency diagnostics and hard-to-reach areas (Fig. 4). Comparative workflow of sample transport models. The diagram contrasts the high-risk “Cold Chain” dependent route with adaptive, resilient alternatives like Dried Blood Spots (DBS) and Unmanned Aerial Vehicles (UAVs) that bypass infrastructural barriers Human-centered strategies: training, competence, and culture Although infrastructure gaps are more obvious in RLS, the human element remains the most critical determinant of sample quality. The majority of pre-analytical errors such as haemolysis from vigorous tube shaking or labelling mistakes, are driven by human behaviour and can be mitigated without expensive equipment. However, sustaining these behavioural changes requires moving beyond traditional didactic training models. Bridging the theory–practice gap A pervasive challenge in laboratory capacity building is the disconnect between theoretical knowledge and daily practice. Standardized training programs are effective at imparting knowledge; for instance, a quasi-experimental study in Cape Town, South Africa, demonstrated that a targeted phlebotomy training program raised the average knowledge scores of healthcare professionals from approximately 60% to 96%. Crucially, however, this dramatic increase in knowledge did not translate into a statistically significant reduction in the rate of sample rejection in the immediate aftermath [18]. This finding shows that one-off training events are insufficient to override the systemic pressures of high workloads, understaffing, and fatigue that lead to procedural shortcuts. To address this, the SLMTA 1 (2025 Edition) curriculum has been updated to align with ISO 15189:2022, emphasizing that sustainable competence requires a shift towards continuous mentorship and supportive supervision rather than didactic methods [55]. Successful interventions couple initial training with ongoing, non-punitive spot-checks and refresher courses that reinforce best practices in the actual work environment, bridging the gap between classroom theory and the chaotic reality of the clinic [56]. Visualizing standards for adherence In settings where staff may have varying levels of literacy or speak different local languages, traditional, text-heavy Standard Operating Procedures (SOPs) often become “shelfware” (documents that are filed away but rarely consulted) [57]. To enhance adherence, laboratories are increasingly adopting simplified, visual SOPs. Visual aids that transcend language barriers have proven particularly effective for high-frequency error points [39, 40]. For example, an “order of draw” chart using color-coded tubes (Fig. 5) provides a rapid, point-of-care cognitive cue to prevent additive cross-contamination. Similarly, step-by-step pictorial technique guides (Fig. 6) illustrating venepuncture angle and correct tube inversion offer clear, standardized instruction that reinforces safe practice without reliance on text. Order of Draw. A visual guide showing the correct order of blood collection using color-coded tubes to minimize additive carryover and pre-analytical error SOP for Clinical Venepuncture Procedure. Pictorial standard operating procedure illustrating correct venepuncture technique and tube handling, using minimal text and visual cues to support adherence across varying literacy levels Cultivating a just culture of quality Perhaps the most profound barrier to quality improvement is the organizational culture. In many RLS institutions, error is treated with punishment, leading to a “culture of blame” where mistakes are hidden rather than reported [58–61]. A sustainable QMS requires shifting to a non-punitive culture where staff feel safe to report errors (e.g., a mislabelled tube) without fear of retribution [62]. When quality is framed as a shared responsibility, where a rejected sample is seen as a system failure to be analysed rather than a personal failure to be punished, reporting rates improve, allowing managers to identify and address root causes. Pre-analytical oversight: manual quality metrics and feedback loops Effective pre-analytical oversight does not require the sophisticated automation found in high-income countries. In RLS, rigorous monitoring of specimen quality indicators can be achieved through pragmatic, manual tracking systems that capture collection variances, document sample non-conformities, and enforce strict traceability prior to analysis. Manual quality control in the absence of automation The foundation of manual oversight is the rigorous use of paper-based logs. A simple Rejection Logbook maintained at the specimen reception desk transforms anecdotal observations into actionable data. By recording specific variables like patient ID, ward/clinic of origin, and reason for rejection (e.g., haemolysis, clot), for every rejected sample, managers can generate longitudinal data to identify specific departments, units or shifts where errors are most frequent [12, 63]. Data-Driven Intervention: Instead of generic hospital-wide complaints, a manager can use logbook data to pinpoint, for example, that “80% of haemolyzed samples are originating from the emergency ward during the night shift,” allowing for a precise, high-impact training intervention. Data-Driven Intervention: Instead of generic hospital-wide complaints, a manager can use logbook data to pinpoint, for example, that “80% of haemolyzed samples are originating from the emergency ward during the night shift,” allowing for a precise, high-impact training intervention. Internal Pre-Analytical Competence Testing: To monitor staff proficiency in screening specimen defects without expensive external programs, laboratories can implement blind audits by re-introducing previously flagged patient samples (such as borderline hemolyzed or underfilled tubes) back into the intake workflow. This verifies the consistency of intake staff in successfully detecting and logging pre-analytical non-conformities, creating a zero-cost internal check on frontline screening reliability. Internal Pre-Analytical Competence Testing: To monitor staff proficiency in screening specimen defects without expensive external programs, laboratories can implement blind audits by re-introducing previously flagged patient samples (such as borderline hemolyzed or underfilled tubes) back into the intake workflow. This verifies the consistency of intake staff in successfully detecting and logging pre-analytical non-conformities, creating a zero-cost internal check on frontline screening reliability. Pragmatic external quality assessment (EQA) Although formal external quality programs are often cost-prohibitive, peer-laboratory exchange networks can serve as a low-cost alternative to validate and standardize pre-analytical screening thresholds. Under this model, neighbouring facilities exchange a standard panel of specimens displaying specific pre-analytical defects such as variable clotting or visually graded haemolysis, to ensure that specimen rejection decisions remain uniform across different facilities. Organizing these cross-checking exchanges regionally allows resource-limited laboratories to benchmark their pre-analytical screening criteria against one another without relying on expensive international providers [64]. Feedback loops and policy alignment Pre-analytical improvement relies on closing the communication loop between the laboratory and the clinic [24, 65]. Low-Cost Digital Feedback: Mobile technology facilitates rapid, bidirectional feedback. Secure instant messaging platforms such as WhatsApp have been widely adopted in clinical settings to enable real-time communication and the sharing of clinical images between healthcare workers, improving responsiveness and decision-making [66]. In laboratory workflows, this allows immediate feedback on sample quality (e.g., sharing an image of a clotted specimen with the collecting nurse) which may be more impactful for behaviour change than delayed, aggregate reporting. Low-Cost Digital Feedback: Mobile technology facilitates rapid, bidirectional feedback. Secure instant messaging platforms such as WhatsApp have been widely adopted in clinical settings to enable real-time communication and the sharing of clinical images between healthcare workers, improving responsiveness and decision-making [66]. In laboratory workflows, this allows immediate feedback on sample quality (e.g., sharing an image of a clotted specimen with the collecting nurse) which may be more impactful for behaviour change than delayed, aggregate reporting. Policy Integration: These operational strategies must be anchored in national policy. Ministries of Health are urged to integrate these pragmatic quality measures into National Laboratory Strategic Plans, ensuring that “quality” is defined not just by accreditation status, but by the functional implementation of these error-reduction strategies at the facility level [65]. Policy Integration: These operational strategies must be anchored in national policy. Ministries of Health are urged to integrate these pragmatic quality measures into National Laboratory Strategic Plans, ensuring that “quality” is defined not just by accreditation status, but by the functional implementation of these error-reduction strategies at the facility level [65]. Technological enablers: digital tools and context-appropriate innovation Human-centered strategies form the cultural bedrock of quality, but the strategic integration of technology acts as a force multiplier. In resource-limited settings (RLS), “appropriate technology” does not imply inferior technology; rather, it refers to solutions explicitly designed to function within the constraints of the local environment [67, 68]. These often entails prioritizing open-source software, resilience to power instability, and maintainability. Digital transformation with open-source tools The transition from paper-based registers to digital Laboratory Information Systems (LIS) is a pivotal step in reducing pre-analytical error. Paper systems are inherently prone to transcription mistakes, illegible handwriting, and data loss, making longitudinal quality monitoring nearly impossible [24, 69]. Unfortunately, commercial LIS solutions are often prohibitively expensive and too complex for smaller RLS laboratories. In response, open-source solutions like the Basic Laboratory Information System (BLIS) have demonstrated remarkable efficacy. Developed specifically for the African context, BLIS operates on local servers to minimize reliance on unstable internet connections [67, 70, 71]. Evidence from a rigorously evaluated implementation in Cameroon highlights the transformative potential of such tools. The introduction of BLIS resulted in a 49.5% average reduction in laboratory errors, including transcription mistakes and invalidated results. Furthermore, operational efficiency surged: the time required for patient registration decreased by 48% (dropping from an average of 52 s to 27 s), and the overall administrative workload was reduced by 66.6%. Crucially, these efficiency gains translated into financial sustainability; the ability to process higher patient volumes contributed to a 34.5% increase in laboratory revenue, creating a pathway for the system to become self-sustaining rather than donor-dependent [71]. This transition is central to the ASLM Laboratory Quality Management System (LQMS) Strategy 2025–2029, which specifically advocates for the conversion of laboratory expertise into sustainable national policy, reducing reliance on external donors [65]. Mobile and QR solutions Mobile technology offers a unique opportunity for RLS to bypass traditional infrastructure requirements. The near-ubiquitous availability of smartphones allows them to replace expensive, dedicated hardware like barcode scanners [72, 73]. Emerging protocols utilize QR codes generated for patient request forms. At every stage of the pre-analytical chain, from bedside collection to transport and laboratory receipt, staff can scan these codes using standard smartphone cameras. This action logs the sample’s location, timestamp, and handler identity into a central database, creating a digital chain of custody that virtually eliminates sample loss and misidentification [24, 42]. This approach leverages existing personal hardware to build a sophisticated tracking network with minimal capital investment. The limits of automation Although automation is desirable, this study cautions against the uncritical adoption of high-throughput robotic track systems common in the West. In RLS, such systems often become underutilized capital assets due to the inability to source reagents or secure maintenance. “Appropriate automation” in this context refers to robust, semi-automated analysers and process aids that are locally maintainable and tolerant of environmental fluctuations [14, 67, 68]. Implementation realities: lessons for scalability and sustainability The history of global health interventions is replete with technologies that failed not due to technical flaws, but due to socio-technical misalignment, a failure to account for the human, organizational, and infrastructural context. The socio-technical challenge Successful implementation requires addressing the “people” side of technology. A significant barrier is the baseline digital literacy of the workforce; many staff may require fundamental computer skills training before they can effectively use an LIS [74]. Theoretical frameworks such as the Technology Acceptance Mode l (TAM) elucidate this resistance, positing that adoption relies on two key perceptions: “perceived usefulness” and “perceived ease of use.” If laboratory staff perceive a new digital tracking tool as merely adding to their administrative burden without simplifying their workflow (low perceived usefulness), adoption will stall regardless of administrative mandates [73]. Furthermore, psychological resistance to change and fear of new accountability measures can lead to poor adoption [62, 74]. Strategies that succeed prioritize user-centric design and involve local staff in the implementation process to build ownership. Infrastructure and financial sustainability Infrastructure deficits remain the primary antagonist to scalability. Unstable electricity grids necessitate that any digital deployment includes a budget for backup power, such as solar systems with battery storage, to prevent system downtime [16]. Financial sustainability is equally critical as the prevalent donor-driven model, characterized by short-term funding cycles (typically 1–3 years), often leaves laboratories without the resources to pay for software updates or technical support once the project concludes [75, 76]. Sustainable models must shift focus from initial capital expenditure to Total Cost of Ownership (TCO), ensuring that local Ministries of Health have a clear roadmap for absorbing operational costs [67, 76]. Overcoming fragmentation A final, critical lesson is the need to combat fragmentation. Vertical disease programs (e.g., HIV, TB, Malaria) often fund separate, non-interoperable data systems, forcing laboratory staff to perform duplicate data entry across multiple platforms [67, 76]. This redundancy increases workload and transcription error rates [24, 67]. Future implementations must mandate interoperability standards, ensuring that a single LIS can report data to all relevant national programs, thereby streamlining workflow and improving data quality [69, 77]. Policy implications, strategic recommendations, and future research National regulatory bodies must anchor these operational strategies in the latest international handling, transport, and storage standards, such as CLSI PRE04 (2025) [40]. To translate these findings into systemic improvement, stakeholders must move beyond disjointed interventions. A consolidated framework of stakeholder-specific, actionable recommendations is outlined in Table 3. The following strategic imperatives are recommended for laboratory leadership, national policymakers, and global health partners: Institutionalize Quality Metrics: Ministries of Health must mandate the collection and reporting of key pre-analytical indicators (e.g., rejection rates due to haemolysis, mislabelling) within National Laboratory Strategic Plans. “Quality” must be redefined operationally: a laboratory cannot be considered functional if its rejection rates exceed established thresholds, regardless of its analytical equipment [4, 63, 64]. Institutionalize Quality Metrics: Ministries of Health must mandate the collection and reporting of key pre-analytical indicators (e.g., rejection rates due to haemolysis, mislabelling) within National Laboratory Strategic Plans. “Quality” must be redefined operationally: a laboratory cannot be considered functional if its rejection rates exceed established thresholds, regardless of its analytical equipment [4, 63, 64]. Prioritize Total Cost of Ownership in Funding: International donors and development partners should restructure funding models to prioritize long-term sustainability over initial capital investment. Grants for digital systems or automated analysers must include dedicated budget lines for post-implementation maintenance, local server management, and continuous staff training to prevent the graveyard of equipment phenomenon [67, 75]. Prioritize Total Cost of Ownership in Funding: International donors and development partners should restructure funding models to prioritize long-term sustainability over initial capital investment. Grants for digital systems or automated analysers must include dedicated budget lines for post-implementation maintenance, local server management, and continuous staff training to prevent the graveyard of equipment phenomenon [67, 75]. Harmonize Digital Ecosystems: To combat data disintegration, national regulatory bodies must enforce interoperability standards (e.g., HL7 FHIR) for all new laboratory information systems. This ensures that data from vertical programs (HIV, TB, AMR) flows into a unified national repository, enabling real-time surveillance and decision-making [69, 76, 77]. Harmonize Digital Ecosystems: To combat data disintegration, national regulatory bodies must enforce interoperability standards (e.g., HL7 FHIR) for all new laboratory information systems. This ensures that data from vertical programs (HIV, TB, AMR) flows into a unified national repository, enabling real-time surveillance and decision-making [69, 76, 77]. Table 3Framework of actionable recommendations for key stakeholders [15, 62, 63, 65, 67, 69, 71, 76, 77]Stakeholder groupKey challengeRecommended actionMinistries of Health & PolicymakersFragmented, disease-specific laboratory systemsDevelop integrated National Laboratory Strategic Plans with dedicated funding for quality systemsLack of standardized practicesAdapt and enforce international standards (CLSI, WHO); implement national quality indicatorsNGOs, Donors & Implementing PartnersShort-term, unsustainable fundingShift to long-term system-strengthening models with sustainability plansDeployment of inappropriate technologiesFund context-appropriate, interoperable, and maintainable solutionsLaboratory Managers & DirectorsHigh error rates with limited resourcesImplement low-cost quality systems (visual SOPs, audits, feedback loops)Limited quality monitoring systemsEstablish internal QA programs; use LIS data for continuous monitoring Framework of actionable recommendations for key stakeholders [15, 62, 63, 65, 67, 69, 71, 76, 77] Although the technical feasibility of many interventions is established, a critical evidence gap remains regarding their economic value. Future implementation science research should prioritize rigorous cost-consequence analyses that quantify the return on investment (ROI) of pre-analytical quality control. Specifically, data is needed to demonstrate how reducing sample rejection rates translates into direct savings for health systems and improved patient outcomes. Crucially, the foremost priority for future research must center on the behavioural economics of laboratory staff as a core determinant of quality sustainability. While technical interventions and adaptive protocols are structurally sound, their efficacy is entirely dependent on the consistent compliance of human actors working under systemic stress. Future studies should apply behavioural economics frameworks to investigate how cognitive biases, local incentive structures, and specific workplace environments influence procedural compliance. Uncovering these hidden psychosocial and behavioural drivers is essential to design systems that naturally encourage adherence, thereby closing the persistent gap between classroom training and daily clinical practice [55, 56, 58, 59, 62]. Strengths and limitations of the study The primary strength of this review lies in its multi-dimensional search strategy, which spans a comprehensive 15-year period from 2010 to 2025 and integrates both high-impact peer-reviewed literature and critical grey literature from global health bodies such as the WHO and the CDC. Study selection followed a transparent PRISMA-informed screening process which included studies based on a criticality matrix. By utilizing the Three Pillars of Intervention framework, the study moves beyond traditional academic summaries to offer a pragmatic roadmap that explicitly addresses the theory–practice gap inherent in resource-limited settings. Furthermore, the inclusion of implementation-focused evidence, such as field cases on drone delivery, motorcycle courier networks, and open-source laboratory information systems, provides a high degree of operational relevance. However, certain limitations must be acknowledged, most notably a potential bias toward English-language publications, which may have excluded relevant regional research from non-Anglophone resource-limited contexts. The review also highlights a significant evidence gap regarding long-term, quantitative outcome data and rigorous cost-consequence analyses for many of the proposed interventions, such as passive cooling or mobile tracking tools. Although case studies and pilot implementations provide valuable proof-of-concept, there remains a paucity of robust longitudinal data demonstrating sustained impact and cost-effectiveness in real-world settings. Furthermore, the use of targeted application-specific search terms to identify implementation case studies may have favoured certain technologies or platforms over comparable alternatives, despite efforts to capture a broad range of evidence. Finally, while the purposive selection of 71 sources ensured technical depth, the inherent heterogeneity of literature in these settings makes it challenging to provide a singular, universally applicable metric for success across all diverse laboratory ecosystems. Conclusion Strengthening pre-analytical quality in resource-limited settings is an operational and clinical necessity to safeguard patient safety and promote health equity. This review establishes that while infrastructural gaps, transport networks, and workforce deficits heavily drive specimen errors, diagnostic reliability can be systematically achieved through context-adapted interventions rather than the rigid replication of high-resource paradigms. By integrating the three pillars framework including deploying adaptive protocols like dried blood spots to bypass cold chain constraints, transitioning to non-punitive organizational cultures supported by continuous mentorship and visual protocols, and scaling up maintainable digital ecosystems such as open-source laboratory information systems, underserved laboratories can significantly decrease sample rejection rates and maximize data integrity. Ultimately, sustainable progress requires national policy alignment, funding models centered on the total cost of ownership, and future implementation research focused on the behavioural economics of the healthcare workforce to bridge the gap between technical guidelines and daily practical execution. Abbreviations Antimicrobial resistance African society for laboratory medicine Basic Laboratory Information System Centers for Disease Control and Prevention Clinical and Laboratory Standards Institute Dried Blood Spots Early Infant Diagnosis External quality assessment Fast healthcare interoperability resources Human Immunodeficiency Virus Health Level Seven Internal Proficiency Testing International Organization for Standardization Laboratory Information System Low- and middle-income countries Laboratory quality management system Point-of-care testing Preferred reporting items for systematic reviews and meta-analyses Quality assurance Quality control Quality management system Quick response Resource-limited setting Strengthening Laboratory Management Toward Accreditation Standard operating procedure Sub-Saharan Africa Technology Acceptance Model Tuberculosis Total cost of ownership Total testing process Unmanned aerial vehicle World Health Organization Author contributions BKM and BB contributed equally to this work as co-first authors. BKM and BB were responsible for the study's conceptualization and methodology, with BKM leading the primary literature search and data extraction while BB spearheaded the design of the conceptual framework and technical figures. Co-first authors prepared the initial draft of the manuscript. INM made significant contributions through the validation and critical appraisal of the thematic findings, as well as the substantive review and final editing of the manuscript. AOU contributed to data interpretation and synthesis, supported the drafting of key sections of the manuscript, and participated in critical revisions for important intellectual content. All authors have read and approved the final version for submission. Funding This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Data availability No datasets were generated or analysed during the current study. Declarations Declaration of generative AI in scientific writing During the preparation of this work, the authors used ChatGPT to improve language and readability while the images were generated using the infographic feature of NotebookLM. After using these tools, the authors reviewed and edited the content as needed and take full responsibility for the publication. Disclaimer The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any affiliated agency of the authors. Ethics approval and consent to participate This article followed all ethical standards for research without direct contact with human or animal subjects. Competing interests The authors declare no competing interests. Footnotes Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Blessing Kenechi Myke-Mbata and Bruno Basil have contributed equally to this work and share first authorship. References Associated Data Data Availability Statement No datasets were generated or analysed during the current study.